Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Tubacin and bortezomib induce synergistic antitumor activity in MM cell lines
87(2):162-73
5)6)30(25)43-19-8-10-29(42)35-13-9-14-36-39-34/h11-12
Lactacystin also inhibits the lysosomal enzyme cathepsin A
InChiKey: FBTSQILOGYXGMD-UHFFFAOYSA-N
galacto-Dapagliflozin Size:Contact [email protected] for quotation Tubacin and bortezomib induce synergisticKi = 2 nM galacto Dapagliflozin is a potent inhibitor of human SGLT2. Renal glucose transport is mediated by sodium glucose cotransporters (SGLT) 1 and 2. In humans, SGLT2 is responsible for the majority of glucose reabsorption in the kidney. In vitro: It was found that galacto dapagliflozin was a selective inhibitor of hSGLT2, but was less potent than dapagliflozin for both transporters. Both phlorizin and galacto dapagliflozin rapidly dissociated